Skip to main content
David Stein, MD, Pulmonology, Pasadena, TX

DavidASteinMD

Pulmonology Pasadena, TX

Critical Care Medicine, Pleural Disease

Physician

Are you Dr. Stein?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 50 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    4003 Woodlawn Ave
    Pasadena, TX 77504
    Phone+1 713-941-0088
    Fax+1 713-941-4798

Summary

  • Dr. David Stein, MD is a pulmonologist in Pasadena, Texas. He is currently licensed to practice medicine in Texas and Louisiana. He is affiliated with HCA Houston Healthcare Southeast, St. Luke's Health - Patients Medical Center, and St. Luke's Health - Baylor St. Luke's Medical Center.

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonFellowship, Pulmonary Disease and Critical Care Medicine, 1978 - 1980
  • Louisiana State University School of Medicine
    Louisiana State University School of MedicineInternship, Internal Medicine, 1976 - 1977
  • New York Medical College
    New York Medical CollegeClass of 1975

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1978 - 2026
  • LA State Medical License
    LA State Medical License 1975 - 2006
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
  • Top MD Consumers Checkbook

Publications & Presentations

PubMed

Press Mentions

  • Babson Diagnostics Raises $31 Million in Series B Funding to Drive Retailization of Customer-First, Convenient, and Highly Accessible Diagnostic Blood Testing
    Babson Diagnostics Raises $31 Million in Series B Funding to Drive Retailization of Customer-First, Convenient, and Highly Accessible Diagnostic Blood TestingJune 29th, 2021
  • Babson Diagnostics Named Fierce MedTech "Fierce 15" Company
    Babson Diagnostics Named Fierce MedTech "Fierce 15" CompanyMarch 9th, 2021
  • Babson Diagnostics First to Conduct Full Blood Panel Testing from a Finger Sample in a Retail Setting
    Babson Diagnostics First to Conduct Full Blood Panel Testing from a Finger Sample in a Retail SettingJanuary 25th, 2021
  • Join now to see all